Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

Delayed Data
As of Aug 18
 +0.61 / +3.21%
Today’s Change
Today|||52-Week Range
Mylan Finalizes Settlement Agreement with DOJ for $465M
Aug 18 / Zacks.com - Paid Partner Content
Shire Gains as it Seeks European Approval For Dry Eye Treatment
Aug 15 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY's Op...
Aug 18 / Zacks.com - Paid Partner Content
Ionis Pharmaceuticals Retains Rights to Inotersen, Stock Up
Aug 14 / Zacks.com - Paid Partner Content
Hikma Sinks on Advair Generic Concerns
Aug 17 / TheStreet.com - Paid Partner Content
Stocks That Fell to 3-Year Lows in the Week of August 11
Aug 13 / GuruFocus News - Paid Partner Content
Orleans Capital Management Corp Buys SPDR Select Sector Fund - Consumer Discretionary...
Aug 15 / GuruFocus News - Paid Partner Content
Mylan (MYL) Misses on Q2 Earnings & Sales, Lowers View
Aug 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close18.99
Today’s open19.55
Day’s range18.90 - 19.60
Average volume (3 months)2,278
Market cap$96.4B
Dividend yield5.48%
Data as of 3:49pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-90.47%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.96%
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$37.6B
Annual profit (last year)$1.2B
Net profit margin3.27%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London